PL4129989T3 - Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanie - Google Patents
Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanieInfo
- Publication number
- PL4129989T3 PL4129989T3 PL21860426.2T PL21860426T PL4129989T3 PL 4129989 T3 PL4129989 T3 PL 4129989T3 PL 21860426 T PL21860426 T PL 21860426T PL 4129989 T3 PL4129989 T3 PL 4129989T3
- Authority
- PL
- Poland
- Prior art keywords
- dipeptidylpeptidase
- inhibitor
- application
- nitrile derivative
- derivative acting
- Prior art date
Links
- 102100029921 Dipeptidyl peptidase 1 Human genes 0.000 title 1
- 101710087078 Dipeptidyl peptidase 1 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002825 nitriles Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010871912 | 2020-08-26 | ||
| CN202011129809 | 2020-10-21 | ||
| CN202110167731 | 2021-02-07 | ||
| PCT/CN2021/114500 WO2022042591A1 (zh) | 2020-08-26 | 2021-08-25 | 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4129989T3 true PL4129989T3 (pl) | 2025-02-24 |
Family
ID=80354645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21860426.2T PL4129989T3 (pl) | 2020-08-26 | 2021-08-25 | Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanie |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US11807635B2 (pl) |
| EP (2) | EP4497473A3 (pl) |
| JP (1) | JP7657291B2 (pl) |
| KR (1) | KR102992756B1 (pl) |
| CN (1) | CN115996923B (pl) |
| AU (1) | AU2021330865B2 (pl) |
| BR (1) | BR112023003492A2 (pl) |
| CA (1) | CA3190610A1 (pl) |
| CL (1) | CL2023000532A1 (pl) |
| DK (1) | DK4129989T3 (pl) |
| ES (1) | ES3008541T3 (pl) |
| FI (1) | FI4129989T3 (pl) |
| HR (1) | HRP20241656T1 (pl) |
| HU (1) | HUE069470T2 (pl) |
| IL (1) | IL300855A (pl) |
| LT (1) | LT4129989T (pl) |
| MX (1) | MX2023002371A (pl) |
| PL (1) | PL4129989T3 (pl) |
| PT (1) | PT4129989T (pl) |
| RS (1) | RS66302B1 (pl) |
| SI (1) | SI4129989T1 (pl) |
| SM (1) | SMT202400510T1 (pl) |
| TW (1) | TW202214616A (pl) |
| WO (1) | WO2022042591A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220119653A (ko) | 2019-12-20 | 2022-08-30 | 테나야 테라퓨틱스, 인코포레이티드 | 플루오로알킬-옥사디아졸 및 이의 용도 |
| BR112023003423A2 (pt) | 2020-08-26 | 2023-03-21 | Vertex Pharma | Inibidores de apol1 e métodos de uso destes |
| PL4129989T3 (pl) * | 2020-08-26 | 2025-02-24 | Haisco Pharmaceuticals Pte. Ltd. | Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanie |
| CN114591315A (zh) * | 2020-12-04 | 2022-06-07 | 瑞石生物医药有限公司 | 一种组织蛋白酶c小分子抑制剂 |
| WO2022166721A1 (zh) * | 2021-02-05 | 2022-08-11 | 南京明德新药研发有限公司 | 含1，4-氧杂氮杂环庚烷的并环类衍生物 |
| US20240252502A1 (en) | 2021-05-04 | 2024-08-01 | Tenaya Therapeutics, Inc. | Hdac6 inhibitors for treatment of metabolic disease and hfpef |
| CN115925696A (zh) * | 2021-10-29 | 2023-04-07 | 瑞石生物医药有限公司 | 一种1-氰基-2-苯基乙基甲酰胺衍生物及其用途 |
| JP2025506307A (ja) * | 2022-02-22 | 2025-03-07 | ハイスコ ファーマスーティカル プライベート リミテッド | 含窒素複素環化合物の調製方法 |
| WO2023160542A1 (zh) * | 2022-02-22 | 2023-08-31 | 四川海思科制药有限公司 | 二肽基肽酶抑制剂化合物的盐及晶型 |
| CN115785083A (zh) * | 2022-12-27 | 2023-03-14 | 瑞石生物医药有限公司 | 一种组织蛋白酶c小分子抑制剂及其制备方法 |
| JP2026503035A (ja) | 2023-01-06 | 2026-01-27 | インスメッド インコーポレイテッド | 新規な可逆性ｄｐｐ１阻害剤及びその用途 |
| CN120693326A (zh) * | 2023-02-15 | 2025-09-23 | 英斯梅德股份有限公司 | 某些1，4-氧杂氮杂环庚烷-2-甲酰胺作为dpp1抑制剂的用途 |
| AU2024237520A1 (en) * | 2023-03-16 | 2025-09-11 | Insmed Incorporated | Dpp1 inhibitors with polycyclic linkers and uses thereof |
| JP2026510407A (ja) | 2023-03-23 | 2026-04-02 | ハイスコ ファーマスーティカル プライベート リミテッド | ジペプチジルペプチダーゼ小分子阻害剤を含む医薬組成物 |
| WO2025056038A1 (en) * | 2023-09-15 | 2025-03-20 | Insmed Incorporated | Dipeptidyl peptidase 1 inhibitors and uses thereof |
| WO2025162472A1 (en) | 2024-01-31 | 2025-08-07 | Insmed Incorporated | Linear dipeptidyl peptidase 1 inhibitors and uses thereof |
| AU2025252911A1 (en) * | 2024-04-12 | 2026-08-06 | Insmed Incorporated | Dipeptidyl peptidase 1 inhibitors and uses thereof |
| TW202606713A (zh) * | 2024-06-27 | 2026-02-16 | 中國商北京泰德製藥股份有限公司 | 組織蛋白酶c抑制劑化合物及其應用 |
| WO2026083346A1 (en) * | 2024-10-18 | 2026-04-23 | Insmed Incorporated | Dpp1 inhibitors with cyclic or linear linkers and uses thereof |
| WO2026130448A1 (zh) * | 2024-12-19 | 2026-06-25 | 广州呼吸药物工程技术有限公司 | 肽基腈类化合物及其制备方法和用途 |
| WO2026130449A1 (zh) * | 2024-12-19 | 2026-06-25 | 广州呼吸药物工程技术有限公司 | 一种磺内酰胺类化合物及其制备方法和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6462076B2 (en) | 2000-06-14 | 2002-10-08 | Hoffmann-La Roche Inc. | Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| PL370766A1 (pl) | 2001-12-04 | 2005-05-30 | F.Hoffmann-La Roche Ag | Podstawione 2-aminocykloalkanokarboksyamidy i ichzastosowanie jako inhibitorów proteaz cysteinowych |
| WO2004110988A1 (en) | 2003-06-18 | 2004-12-23 | Prozymex A/S | Protease inhibitors |
| US7902181B2 (en) | 2007-12-12 | 2011-03-08 | Astrazeneca Ab | Compounds 010 |
| EA201190235A1 (ru) | 2009-05-07 | 2012-05-30 | Астразенека Аб | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 |
| AU2010319927B2 (en) * | 2009-10-29 | 2015-01-22 | Janssen Pharmaceutica Nv | Alkynyl derivatives useful as DPP-1 inhibitors |
| WO2012119941A1 (en) | 2011-03-04 | 2012-09-13 | Prozymex A/S | Peptidyl nitrilcompounds as peptidase inhibitors |
| US8999975B2 (en) | 2011-09-19 | 2015-04-07 | Boehringer Ingelheim International Gmbh | Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C |
| JP6441830B2 (ja) | 2013-03-14 | 2018-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | カテプシンｃの置換２−アザ−ビシクロ［２．２．１］ヘプタン−３−カルボン酸（シアノ−メチル）−アミド阻害剤 |
| WO2015032942A1 (en) * | 2013-09-09 | 2015-03-12 | Prozymex A/S | N-substituted 3,3'-(biphenyl-4,4'-diyl)bis-2-aminopropanenitriles as dppi inhibitors |
| NO2699580T3 (pl) * | 2014-01-24 | 2018-02-24 | ||
| WO2016016242A1 (en) | 2014-08-01 | 2016-02-04 | Boehringer Ingelheim International Gmbh | Substituted oxetanes and their use as inhibitors of cathepsin c |
| WO2016139355A1 (en) * | 2015-03-05 | 2016-09-09 | Prozymex A/S | N-substituted 3,3'-(biphenyl-4,4'-diyl)bis-2-aminopropanenitriles as dppi inhibitors |
| EP3286172B1 (en) | 2015-04-23 | 2019-06-12 | Constellation Pharmaceuticals, Inc. | Lsd1 inhibitors and uses thereof |
| CN107922315B (zh) | 2015-08-29 | 2021-03-26 | 广东东阳光药业有限公司 | 组织蛋白酶k抑制剂及其用途 |
| EP3749326A4 (en) * | 2018-02-07 | 2021-11-03 | Insmed Incorporated | CERTAIN (2S) -N - [(1S) -1-CYANO-2-PHENYLETHYL] -1,4-OXAZEPAN-2-CARBOXAMIDE FOR THE TREATMENT OF VASCULITIDES ASSOCIATED WITH ANCA |
| PH12022551102A1 (en) | 2019-11-08 | 2023-11-20 | Revolution Medicines Inc | Bicyclic heteroaryl compounds and uses thereof |
| CA3171012A1 (en) | 2020-02-20 | 2021-08-26 | Hutchison Medipharma Limited | Heteroaryl heterocyclic compounds and uses thereof |
| JP7873057B2 (ja) | 2020-03-31 | 2026-06-11 | アムジエン・インコーポレーテツド | Ｍｃｌ－１化合物のメチル化 |
| PL4129989T3 (pl) * | 2020-08-26 | 2025-02-24 | Haisco Pharmaceuticals Pte. Ltd. | Pochodna nitrilu działająca jako inhibitor dipeptydylopeptydazy 1 i jej zastosowanie |
-
2021
- 2021-08-25 PL PL21860426.2T patent/PL4129989T3/pl unknown
- 2021-08-25 SM SM20240510T patent/SMT202400510T1/it unknown
- 2021-08-25 AU AU2021330865A patent/AU2021330865B2/en active Active
- 2021-08-25 MX MX2023002371A patent/MX2023002371A/es unknown
- 2021-08-25 CN CN202180052880.5A patent/CN115996923B/zh active Active
- 2021-08-25 ES ES21860426T patent/ES3008541T3/es active Active
- 2021-08-25 HR HRP20241656TT patent/HRP20241656T1/hr unknown
- 2021-08-25 EP EP24203736.4A patent/EP4497473A3/en active Pending
- 2021-08-25 BR BR112023003492A patent/BR112023003492A2/pt unknown
- 2021-08-25 TW TW110131432A patent/TW202214616A/zh unknown
- 2021-08-25 CA CA3190610A patent/CA3190610A1/en active Pending
- 2021-08-25 FI FIEP21860426.2T patent/FI4129989T3/fi active
- 2021-08-25 SI SI202130240T patent/SI4129989T1/sl unknown
- 2021-08-25 IL IL300855A patent/IL300855A/en unknown
- 2021-08-25 EP EP21860426.2A patent/EP4129989B1/en active Active
- 2021-08-25 RS RS20241381A patent/RS66302B1/sr unknown
- 2021-08-25 WO PCT/CN2021/114500 patent/WO2022042591A1/zh not_active Ceased
- 2021-08-25 PT PT218604262T patent/PT4129989T/pt unknown
- 2021-08-25 LT LTEPPCT/CN2021/114500T patent/LT4129989T/lt unknown
- 2021-08-25 DK DK21860426.2T patent/DK4129989T3/da active
- 2021-08-25 JP JP2023512049A patent/JP7657291B2/ja active Active
- 2021-08-25 KR KR1020237009666A patent/KR102992756B1/ko active Active
- 2021-08-25 HU HUE21860426A patent/HUE069470T2/hu unknown
-
2022
- 2022-10-28 US US17/976,291 patent/US11807635B2/en active Active
-
2023
- 2023-02-23 CL CL2023000532A patent/CL2023000532A1/es unknown
- 2023-09-15 US US18/369,069 patent/US12365673B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4434979A4 (en) | KIF18A INHIBITOR | |
| EP4361142A4 (en) | COMPOUND FOR USE AS A KIF18A INHIBITOR | |
| EP4332103A4 (en) | ATR INHIBITOR COMPOUND CONTAINING A SULFOXIMINE | |
| EP4368620A4 (en) | COMPOUND SERVING AS A KAT6 INHIBITOR | |
| DK3612524T3 (da) | 6-pyrimidin-isoindol-derivat som erk1/2-inhibitor | |
| IL287908A (en) | Compound used as kinase inhibitor and application thereof | |
| EP3782987A4 (en) | BENZOPYRAZOLE COMPOUND AS A RHO CINEMA INHIBITOR | |
| DK3470409T3 (da) | Benzotriazol-afledt Alfa- og Beta-umættet amidforbindelse anvendt som TGF-BRI-hæmmer | |
| EP3992178A4 (en) | ACRYLIC ESTER DERIVATIVE AND USE AND PRODUCTION THEREOF | |
| DK3826982T3 (da) | Anvendelse af en substitueret thiazolidinforbindelse som nitrificeringshæmmer | |
| EP4263502C0 (en) | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | |
| LT4244208T (lt) | Magl inhibitorius | |
| EA200500201A1 (ru) | Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина | |
| EP4619388A4 (en) | CATHEPSIN L INHIBITORS | |
| IL309805A (en) | Caspase-2 inhibitor compounds | |
| EP4493738A4 (en) | SYNERGISTIC BLENDS OF CORROSION INHIBITORS | |
| EP4087217C0 (en) | ESTIMATED APPLICATION USAGE TIME | |
| EP4237409A4 (en) | SOLID STATE FORMS OF HDAC INHIBITOR | |
| PL4214210T3 (pl) | Związki i kompozycje jako inhibitory sppl2a | |
| EP4499106A4 (en) | NUCLEOSIDE LINE-1 INHIBITORS | |
| EP3735404A4 (en) | ASK1 INHIBITOR CONNECTIONS AND USES THEREOF | |
| KR20240099208A9 (ko) | EGFRvIII-표적화 화합물 및 그의 용도 | |
| JP1726769S (ja) | ハンマー | |
| JP1726770S (ja) | ハンマー | |
| PL4108664T3 (pl) | Krystaliczna postać inhibitora jak i jej zastosowanie |